Targeting Cancer Metabolism With Ketogenic Therapy and Fasting
Could metabolic therapies become part of the future of cancer care?
That question sits at the center of Dr. Bret Scher’s conversation with neurologist and researcher Dr. Matthew Phillips, whose recent study explored a metabolic approach in people with glioblastoma, one of the most aggressive forms of brain cancer.
Rather than relying on a single intervention, the study combined a ketogenic diet, intermittent fasting, and repeated five-day fasts alongside standard chemotherapy and radiation. Together, these strategies were designed to lower the Glucose Ketone Index, or GKI, by reducing glucose…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.